The purpose of ICH Q9 is to ensure a systematic and proactive approach to managing risks that may affect product quality, patient safety, and data integrity. It recognizes that risk management should be an integral part of the pharmaceutical quality system and be applied throughout the lifecycle of a product, from development to post-marketing activities.
Overall, ICH Q9(R1) plays a crucial role in promoting a proactive and systematic approach to risk management in the pharmaceutical industry. It aligns with regulatory expectations and industry best practices, ensuring the delivery of safe and effective pharmaceutical products to patients worldwide.
The training session aims to provide participants with an understanding of the International Council for Harmonization (ICH) Q9 guideline, with a focus on the revised version, ICH Q9(R1). Participants will learn about the principles, concepts, and application of the risk management approach outlined in the guideline, and how it relates to the pharmaceutical industry.
This session will discuss some potential applications and tools used in the industry for Quality Risk Management. Additionally, a few examples of how to apply these applications will be reviewed.
Attending this training on ICH Q9 (R1) can provide individuals with the necessary knowledge and skills to implement quality risk management principles effectively. This can lead to regulatory compliance, improved quality systems, cost savings, enhanced decision-making, cross-functional collaboration, and a culture of continuous improvement within the pharmaceutical industry.
After this training, participants will be equipped with a foundational understanding of ICH Q9(R1) and its principles. They will be able to apply risk management practices in their respective roles within the pharmaceutical industry, contributing to improved product quality, patient safety, and regulatory compliance.
Introduction to ICH (Q9) R1 Regulations
Key Concepts and Definitions
Risk Management Process
Overview of the risk management process:
Integration of Risk Management in the Pharmaceutical Industry
Quality Risk Management Methods and Tools
Potential Applications for Quality Risk Management
Quality Assurance/Quality Control Professionals:
Manufacturing and Operations Professionals:
Research and Development Professionals:
Regulatory Affairs Professionals:
Pharmacovigilance and Drug Safety Professionals:
Risk Management Professionals:
Cross-Functional Team Members:
Attending this training on ICH Q9 (R1) can provide individuals with the necessary knowledge and skills to implement quality risk management principles effectively. This can lead to regulatory compliance, improved quality systems, cost savings, enhanced decision-making, cross-functional collaboration, and a culture of continuous improvement within the pharmaceutical industry.
After this training, participants will be equipped with a foundational understanding of ICH Q9(R1) and its principles. They will be able to apply risk management practices in their respective roles within the pharmaceutical industry, contributing to improved product quality, patient safety, and regulatory compliance.
Introduction to ICH (Q9) R1 Regulations
Key Concepts and Definitions
Risk Management Process
Overview of the risk management process:
Integration of Risk Management in the Pharmaceutical Industry
Quality Risk Management Methods and Tools
Potential Applications for Quality Risk Management
Quality Assurance/Quality Control Professionals:
Manufacturing and Operations Professionals:
Research and Development Professionals:
Regulatory Affairs Professionals:
Pharmacovigilance and Drug Safety Professionals:
Risk Management Professionals:
Cross-Functional Team Members:
Meredith Crabtree
Meredith Crabtree has over 25 years’ experience in regulated industries, ranging from Blood, Plasma, Tissue, Laboratory, Pharma, Medical devices, Cosmetics, Supplements, and Animal Health manufacturing and distribution. Meredith works as a Quality Consultant performing label reviews, 3rd party inspections, Consent Decree, and Recall support. She also performs regulatory assessments and Quality training. Meredith has a degree in Medical Technology and is currently obtaining a degree in Quality Systems.
FDA current recommendations related to timely initiation of…
Contractor vs Employee: How to Tell the Difference and What…
Imposter Syndrome: How to Define, Understand & Shift Your E…
Impact Assessments For Supplier Change Notices
Implicit Bias: Becoming Aware of Your Inner Storyteller
Complying with the NEW I-9 and E-Verify Regulations - The I…
The Federal Anti-Kickback Statute & Stark Law: What Physici…
Building an Effective Injury Management Process
Fatal Errors Employers Make When Updating Employee Handbook…
From Awareness to Action: Going Beyond the Law in Preventin…
Understanding the Changes Coming to NCCI's Experience Mod i…
Onboarding is NOT Orientation - How to Improve the New Empl…
5 Proven Ways To Engage & Retain Your Team Even During The …
From Awareness to Action: Going Beyond the Law in Preventin…
FDA Compliance and Clinical Trial Computer System Validation
Form 1099 Update 2023: Latest Forms, Rules and Reporting Re…
Navigating New Paths: Unveiling Your Unique Abilities for a…
Customer Relationship Management: Strategic Methods to Mana…
Strategic Interviewing & Selection: Getting the Right Talen…
Excel - Unleashing the Full Potential of New Functions (Exc…
Amazing (!) AI Tools For Building Your Business
Implementing a Robust Change Control Program - Key Elements…
Project Management for Non-Project Managers - How to Effect…
How to Conduct Annual Product Reviews to Achieve GMP Compli…
What Business Leaders Need to Know About Cybersecurity Prep…
Responding to EEOC Discrimination Charges-What's Your Busin…